Combined Pegaptanib sodium (Macugen) and photodynamic therapy in predominantly classic juxtafoveal choroidal neovascularisation in age related macular degeneration

British Journal of Ophthalmology

Volumn 92, Issue 1, 2008, Pages 74-75

  Calvo González, Cristina ^a,c   Reche Frutos, J ^a   Donate Lopez J ^a   Garcia Feijoo J ^a   Leila, M ^b   Fernandez Perez C ^a   Garcia Sanchez J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Magrabi Eye Hospital   (Egypt)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PEGAPTANIB; ANGIOGENESIS INHIBITOR; APTAMER; VASCULOTROPIN A;

AGED; ARTICLE; BEST CORRECTED VISUAL ACUITY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; EVALUATION AND FOLLOW UP; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; JUXTAFOVEAL CHOROIDAL NEOVASCULARIZATION; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; POOR RESPONSE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VISUAL ACUITY; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG EFFECT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDY; RETINA MACULA DEGENERATION; TREATMENT OUTCOME;

AGED; ANGIOGENESIS INHIBITORS; APTAMERS, NUCLEOTIDE; CHOROIDAL NEOVASCULARIZATION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 38349123856     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.128942     Document Type: Article

References (5)

1. Gragoudas ES, Adamis AP, Cunningham ET, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16.
2. Augustin AJ, Schmidt-Erfurth U. Verteporfin therapy and triamcinolone acetonide: convergent modes of action for treatment of neovascular age-related macular degeneration. Eur J Ophthalmol 2006;16:824- 34.
3. Blair MP, Apte RS, Miskala PH, et al. Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin. Retina 2004;24:501-6.
4. Dhalla MS, Shah GK, Blinder KJ, et al. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration. Retina 2006;26:988-93.
5. Lazic R, Gabric N. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal nevascularization due to age-related macular degeneration. Ophthalmology 2007;114:1179-85.